Ricerca Biosciences LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ricerca Biosciences LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013231
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ricerca Biosciences LLC (Ricerca), formerly Ricerca Inc, a subsidiary of Main Market Partners LLC, is a contract research organization that offers services to accelerate drug development. The organization’s service portfolio includes drug safety and metabolism, chemical development, agrochemicals and other commercial services. Ricerca’s commercial services include analytical chemistry services, specialty chemical manufacturing and aquatic toxicology services; its drug safety services include in vivo and in vitro metabolism, general toxicology, safety pharmacology, ADME, and analytical support services. Its chemical development services include syntetic chemistry, engineering, and API manufactoring services. The organization caters to pharmaceutical, agricultural, chemical, animal nutrition and consumer industries. It collaborates with academia, non-profit organizations, task forces and consultants. Ricerca is headquartered Concord, Ohio, the US.

Ricerca Biosciences LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Main Market Partners Acquires Ricerca Biosciences 10
Partnerships 11
Fulcrum Pharma Enters Into Agreement With Ricerca Biosciences 11
Asset Transactions 12
Olon Acquires Chemical Division from Ricerca Biosciences 12
WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 13
Eurofins Scientific Completes Acquisition Of Pan Labs Pharmacology Unit From Ricerca Biosciences 14
Numira Biosciences Acquires Efficacy Pharmacology Unit From Ricerca Biosciences 15
Ricerca Biosciences LLC – Key Competitors 16
Ricerca Biosciences LLC – Key Employees 17
Ricerca Biosciences LLC – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Other Significant Developments 19
Jun 29, 2017: Ricerca Biosciences Renamed to Concord Biosciences After Sale of Chemical Development Division 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Key Facts 2
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ricerca Biosciences LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Main Market Partners Acquires Ricerca Biosciences 10
Fulcrum Pharma Enters Into Agreement With Ricerca Biosciences 11
Olon Acquires Chemical Division from Ricerca Biosciences 12
WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 13
Eurofins Scientific Completes Acquisition Of Pan Labs Pharmacology Unit From Ricerca Biosciences 14
Numira Biosciences Acquires Efficacy Pharmacology Unit From Ricerca Biosciences 15
Ricerca Biosciences LLC, Key Competitors 16
Ricerca Biosciences LLC, Key Employees 17

★海外企業調査レポート[Ricerca Biosciences LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tenneco Inc (TEN):企業の財務・戦略的SWOT分析
    Tenneco Inc (TEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs suc …
  • Petrolympic Ltd (PCQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • University of Alberta-製薬・医療分野:企業M&A・提携分析
    Summary University of Alberta (UALBERTA) is an educational university that provides undergraduate, international, graduate, continuing studies and open studies programs. The university offers educational programs in agricultural food and nutritional science, English and film studies, history and cla …
  • Centers for Disease Control and Prevention:医療機器:M&Aディール及び事業提携情報
    Summary Centers for Disease Control and Prevention (CDC) a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities fr …
  • Bastide Le Confort Medical SA (BLC)-医療機器分野:企業M&A・提携分析
    Summary Bastide Le Confort Medical SA (Bastide Le) is a medical equipment company that provides personal care products. The company offers medical devices for individuals and home health care professionals. It provides products such as lift chairs and accessories, pillows, cushions and special seati …
  • Nielsen Holdings PLC:企業の戦略・SWOT・財務分析
    Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Nielsen Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • LM Wind Power Holding AS-エネルギー分野:企業M&A・提携分析
    Summary LM Wind Power Holding AS (LM Wind Power), a subsidiary of General Electric Co, is a component supplier to the wind industry. The company designs and manufactures blades on modular technology featuring modular aerodynamics, modular structure and modular manufacturing tooling. Its blades have …
  • Champions Oncology Inc (CSBR):企業の財務・戦略的SWOT分析
    Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumor …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • RPC Astrapak:企業の財務・戦略的SWOT分析
    RPC Astrapak - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • MS&AD Insurance Group Holdings, Inc.:企業の戦略・SWOT・財務分析
    MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Al Ahli Bank of Kuwait KSC:企業の戦略・SWOT・財務情報
    Al Ahli Bank of Kuwait KSC - Strategy, SWOT and Corporate Finance Report Summary Al Ahli Bank of Kuwait KSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • DBS Bank (Hong Kong) Limited:企業の戦略・SWOT・財務情報
    DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report Summary DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Stanbic Ibtc Holdings Plc:企業の戦略・SWOT・財務分析
    Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Leggett & Platt Incorporated:企業のM&A・事業提携・投資動向
    Leggett & Platt Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leggett & Platt Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Reinsurance Group of America Incorporated:企業の戦略・SWOT・財務情報
    Reinsurance Group of America Incorporated - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Nabriva Therapeutics Plc (NBRV):製薬・医療:M&Aディール及び事業提携情報
    Summary Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company’s product candidate includes lefamulin, a pleuromutilin antibiotic, being developed in both intravenous and oral formulations for the treatm …
  • Deutsche Borse Ag:企業の戦略・SWOT・財務分析
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tolero Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tolero Pharmaceuticals Inc (Tolero), a subsidiary of Dainippon Sumitomo Pharma America Holdings Inc, is a drug company that offers medicines to treat cancer and other serious human diseases. The company’s alvocidib is a cyclin dependent kinase inhibitor with selective activity against CDK9 a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆